Non-IBD and noninfectious colitis

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 5, Issue 1, 2008, Pages 28-39

  Nielsen, Ole Haagen ^a   Vainer, Ben ^a   Rask Madsen, Jørgen ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; AMIFOSTINE; ANTIBIOTIC AGENT; AZATHIOPRINE; BERTILIMUMAB; BISMUTH SALICYLATE; BOSWELLIA SERRATA EXTRACT; BUDESONIDE; COLCHICINE; COLESTYRAMINE; CROMOGLYCATE DISODIUM; CYCLOSPORIN A; DIPHENOXYLATE; ETANERCEPT; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LOPERAMIDE; MEPOLIZUMAB; MERCAPTOPURINE; MESALAZINE; PLACEBO; PREDNISOLONE; PROBIOTIC AGENT; SALAZOSULFAPYRIDINE; SALICYLIC ACID DERIVATIVE; STEROID; TACROLIMUS; THALIDOMIDE; UNINDEXED DRUG;

BEHCET DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COLITIS; COLLAGENOUS COLITIS; COLON DISEASE; COLON DIVERTICULOSIS; COLON LAVAGE; COLON PERFORATION; COLON RESECTION; DIARRHEA; DIVERSION COLITIS; DRUG EFFICACY; DRUG TREATMENT FAILURE; EOSINOPHILIC COLITIS; EPIDEMIOLOGICAL DATA; FIBERSCOPE ENDOSCOPY; HIGH FIBER DIET; HISTOPATHOLOGY; HUMAN; INTESTINE NECROSIS; ISCHEMIC COLITIS; LOW DRUG DOSE; LYMPHOCYTIC COLITIS; MICROSCOPIC COLITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIATION COLITIS; RARE DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; UNSPECIFIED SIDE EFFECT;

BEHCET SYNDROME; COLITIS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DIVERTICULUM, COLON; EOSINOPHILIA; HUMANS; RADIOTHERAPY; RISK FACTORS;

EID: 38049083803     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep1005     Document Type: Review

References (102)

1. Jämerot G et al. (1995) Collagenous colitis and fecal stream diversion. Gastroenterology 109: 449-455
2. Chande N et al. (2005) Collagenous colitis and lymphocytic colitis: Patient characteristics and clinical presentation. Scand J Gastroenterol 40: 343-347
3. Taha Y et al. (2004) Vascular endothelial growth factor (VEGF) - a possible mediator of inflammation and mucosal permeability in patients with collagenous colitis. Dig Dis Sci 49: 109-115
4. Pardi DS (2004) Microscopic colitis: An update. Inflamm Bowel Dis 10: 860-870
5. Andresen L et al. (2005) Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis. Gut 54: 503-509
6. Nielsen OH et al. (2004) Microscopic colitis: A missed diagnosis? Lancet 364: 2055-2057
7. Olesen M et al. (2004) Microscopic colitis: A common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut 53: 346-350
8. Pardi DS et al. (2007) The epidemiology of microscopic colitis: A population based study in Olmsted County, Minnesota. Gut 56: 504-508
9. Mullhaupt B et al. (1998) Lymphocytic colitis: Clinical presentation and long term course. Gut 43: 629-633
10. Lazenby AJ (2005) Collagenous and lymphocytic colitis. Semin Diagn Pathol 22: 295-300
11. Goldstein NS and Gyorfi T (1999) Focal lymphocytic colitis and collagenous colitis: Patterns of Crohn's colitis? Am J Surg Pathol 23: 1075-1081
12. Nyhlin N et al. (2006) Systematic review: Microscopic colitis. Aliment Pharmacol Ther 23: 1525-1534
13. Chande N et al. Interventions for treating lymphocytic colitis. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD006096. doi:10.1002/14651858.CD006096.pub2
14. Chande N et al. Interventions for treating collagenous colitis. Cochrane Database of Systematic Reviews 2002, Issue 4. Art. No.: CD003575. doi:10.1002/14651858.CD003575.pub4
15. Feyen B et al. (2004) Meta-analysis: Budesonide treatment for collagenous colitis. Aliment Pharmacol Ther 20: 745-749
16. Yazici H et al. (2007) Behçet's syndrome: Disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 3: 148-155
17. Sakane T et al. (1999) Behçet's disease. N Engl J Med 341: 1284-1291
18. Ehrlich GE (2000) Behçet's disease. N Engl J Med 342: 587-588
19. Zouboulis CC et al. (1997) Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J 38: 411-422
20. Alpsoy E et al. (2002) Interferon alfa-2a in the treatment of Behçet disease: A randomized placebo-controlled and double-blind study. Arch Dermatol 138: 467-471
21. Sfikakis PP (2002) Behçet's disease: A new target for anti-tumour necrosis factor treatment. Ann Rheum Dis 61 (Suppl 2): ii5l-ii53
22. Kurtz MD (1976) Colonoscopic diagnosis of nonspecific ulcer of the colon. Gastrointest Endosc 23: 90-91
23. Alpagut U et al. (2007) Major arterial involvement and review of Behçet's disease. Ann Vasc Surg 21: 232-239
24. Lin P and Liang G (2006) Behçet disease: Recommendation for clinical management of mucocutaneous lesions. J Clin Rheumatol 12: 282-286
25. Lee KS et al. (1997) Surgical treatment of intestinal Behçet's disease. Yonsei Med J 38: 455-460
26. Haas PA et al. (1990) Endoscopic examination of the colon and rectum distal to a colostomy. Am J Gastroenterol 85: 850-854
27. Neut C et al. (1989) Impaired bacterial flora in human excluded colon. Gut 30: 1094-1098
28. Edwards CM et al. (1999) Diversion colitis - new light through old windows. Histopathology 34: 1-5
29. de Oliveira-Neto JP and de Aguilar-Nascimento JE (2004) Intraluminal irrigation with fibers improves mucosal inflammation and atrophy in diversion colitis. Nutrition 20: 197-199
30. Jørgensen J and Mortensen PB (2001) Substrate utilization by intestinal mucosal tissue strips from patients with inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 281: G405-G411
31. Ma CK et al. (1990) Diversion colitis: A clinicopathologic study of 21 cases. Hum Pathol 21: 429-436
32. Eggenberger JC and Farid A (2001) Diversion colitis. Curr Treat Options Gastroenterol 4: 255-259
33. Komorowski RA (1990) Histologic spectrum of diversion colitis. Am J Surg Pathol 14: 548-554
34. Harig JM et al. (1989) Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med 320: 23-28
35. Ordein JJ et al. (1992) Diversion colitis in children with severe gastrointestinal motility disorders. Am J Gastroenterol 87: 88-90
36. Reinus JF and Brandt LJ (1994) Vascular ectasias and diverticulosis. Common causes of lower intestinal bleeding. Gastroenterol Clin North Am 23: 1-20
37. Lamps LW and Knapple, WL (2007) Diverticular disease-associated segmental colitis. Clin Gastroenterol Hepatol 5: 27-31
38. Ludeman L et al. (2002) The pathology of diverticular disease. Best Pract Res Clin Gastroenterol 16: 543-562
39. Shepherd NA (1996) Diverticular disease and chronic idiopathic inflammatory bowel disease: Associations and masquerades. Gut 38: 801-802
40. Campbell K and Steele PJ (1991) Non-steroidal anti-inflammatory drugs and complicated diverticular disease: A case-control study. Br J Surg 78: 190-191
41. Goh H and Bourne R (2002) Non-steroidal anti-inflammatory drugs and perforated diverticular disease: A case-control study. Ann R Coll Surg Engl 84: 93-96
42. Gore S et al. (1992) Endoscopic crescentic fold disease of the sigmoid colon: The clinical and histopathological spectrum of a distinctive endoscopic appearance. Int J Colorectal Dis 7: 76-81
43. Peppercorn MA (1992) Drug-responsive chronic segmental colitis associated with diverticula: A clinical syndrome in the elderly. Am J Gastroenterol 87: 609-612
44. Makapugay LM and Dean PJ (1996) Diverticular disease-associated chronic colitis. Am J Surg Pathol 20: 94-102
45. Ludeman L and Shepherd NA (2002) What is diverticular colitis? Pathology 34: 568-572
46. Fox VL et al. (2002) Eosinophilic esophagitis: Its not just kid's stuff. Gastrointest Endosc 56: 260-270
47. Gonsalves N (2007) Food allergies and eosinophilic gastrointestinal illness. Gastroenterol Clin North Am 36: 75-91, vi
48. Mishra A et al. (1999) Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest 103: 1719-1727
49. Rothenberg ME (1998) Eosinophilia. N Engl J Med 338: 1592-1600
50. Foster PS et al. (1996) Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity and lung damage in a mouse asthma model. J Exp Med 183: 195-201
51. Guajardo JR et al. (2002) Eosinophil-associated gastrointestinal disorders: A world-wide-web based registry. J Pediatr 141: 576-581
52. Sampson HA (1999) Food allergy. Part 1: Immunopathogenesis and clinical disorders. J Allergy Clin Immunol 103: 717-728
53. Rothenberg ME (2004) Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 113: 11-28
54. Chen MJ et al. (2003) Eosinophilic gastroenteritis: Clinical experience with 15 patients. World J Gastroenterol 9: 2813-2816
55. Hogan SP et al. (2001) A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nat Immunol 2: 353-360
56. Broide D and Sriramarao P (2001) Eosinophil trafficking to sites of allergic inflammation. Immunol Rev 179: 163-172
57. Mishra A et al. (2002) Enterocyte expression of the eotaxin and interleukin-5 transgenes induces compartmentalized dysregulation of eosinophil trafficking. J Biol Chem 277: 4406-4412
58. Van Sickle GJ et al. (1985) Milk- and soy protein-induced enterocolitis: Evidence for lymphocyte sensitization to specific food proteins. Gastroenterology 88: 1915-1921
59. Khan S (2005) Eosinophilic gastroenteritis. Best Pract Res Clin Gastroenterol 19: 177-198
60. Kelly KJ et al. (1995) Eosinophilic esophagitis attributed to gastroesophageal reflux: Improvement with an amino acid-based formula. Gastroenterology 109: 1503-1512
61. Le Connie D and Nguyen H (2004) Eosinophilic gastroenteritis, ascites, and pancreatitis: A case report and review of the literature. South Med J 97: 905-906
62. Tan AC et al. (2001) Eosinophilic gastroenteritis treated with non-enteric-coated budesonide tablets. Eur J Gastroenterol Hepatol 13: 425-427
63. Pérez-Millán A et al. (1997) Subserosal eosinophilic gastroenteritis treated efficaciously with sodium cromoglycate. Dig Dis Sci 42: 342-344
64. Copeland BH et al. (2004) Eosinophilia in a patient with cyclical vomiting: A case report. Clin Mol Allergy 2: 7
65. Main S et al. (2006) A potent human anti-eotaxin1 antibody, CAT-213: Isolation by phage display and in vitro and in vivo efficacy. J Pharmacol Exp Ther 319: 1395-1404
66. Zimmermann N et al. (2003) Chemokines in asthma: Cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol 111: 227-242
67. Garrett JK et al. (2004) Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 113: 115-119
68. Cools J et al. (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348: 1201-1214
69. Helbig G et al. (2006) The results of imatinib therapy for patients with primary eosinophilic disorders. Eur J Haematol 76 535-536
70. Sreenarasimhaiah J (2005) Diagnosis and management of ischemic colitis. Curr Gastroenterol Rep 7: 421-426
71. Higgins PD et al. (2004) Systematic review: The epidemiology of ischaemic colitis. Aliment Pharmacol Ther 19: 729-738
72. Sanchez LD et al. (2006) Ischemic colitis in marathon runners: A case-based review. J Emerg Med 30: 321-326
73. Chang JB and Stein TA (2003) Mesenteric ischemia: Acute and chronic. Ann Vasc Surg 17: 323-328
74. Cappell MS (1998) Intestinal (mesenteric) vasculopathy. II. Ischemic colitis and chronic mesenteric ischemia. Gastroenterol Clin North Am 27: 827-860
75. Flobert C et al. (2000) Right colonic involvement is associated with severe forms of ischemic colitis and occurs frequently in patients with chronic renal failure requiring hemodialysis. Am J Gastroenterol 95: 195-198
76. Green BT and Tendler DA (2005) Ischemic colitis: A clinical review. South Med J 98: 217-222
77. Brandt LJ and Boley SJ (11992) Colonic ischemia. Surg Clin North Am 72: 203-229
78. Danse EM et al. (2000) Prognosis of ischemic colitis: Comparison of color doppler sonography with early clinical and laboratory findings. AJR Am J Roentgenol 175: 1151-1154
79. Lefkovitz Z et al. (2002) Radiologic diagnosis and treatment of gastrointestinal hemorrhage and ischemia. Med Clin North Am 86 1357-1399
80. Shirahama M et al. (1999) Colour Doppler ultrasound for the evaluation of bowel wall thickening. Br J Radiol 72: 1164-1169
81. Baixauli J et al. (2003) Investigation and management of ischemic colitis. Cleve Clin J Med 70: 920-926
82. Redan JA et al. (1990) Organ distribution of radiolabeled enteric Escherichia coli during and after hemorrhagic shock. Ann Surg 211: 663-666
83. Longo WE et al. (1997) Outcome of patients with total colonic ischemia. Dis Colon Rectum 40: 1448-1454
84. Brandt LJ and Boley SJ (2000) AGA technical review on intestinal ischemia. American Gastrointestinal Association. Gastroenterology 118: 954-968
85. Parfitt JR and Driman DK (2007) Pathological effects of drugs on the gastrointestinal tract: A review. Hum Pathol 38: 527-536
86. Simi M et al. (1995) Bowel stricture due to ischemic colitis: report of three cases requiring surgery. Hepatogastroenterology 42: 279-281
87. Medina C et al. (2004) Outcome of patients with ischemic colitis: review of fifty-three cases. Dis Colon Rectum 47: 180-184
88. Berthrong M and Fajardo LF (1981) Radiation injury in surgical pathology. Part II. Alimentary tract. Am J Surg Pathol 5: 153-173
89. Berthrong M (1986) Pathologic changes secondary to radiation. World J Surg 10: 155-170
90. Hasleton BS et al. (1985) Vascular changes in radiation bowel disease. Histopathology 9: 517-534
91. Andreyev J (2005) Gastrointestinal complications of pelvic radiotherapy: are they of any importance? Gut 54: 1051-1054
92. Gami B et al. (2003) How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther 18: 987-994
93. De Maria D et al. (1992) Adjuvant radiotherapy of the pelvis with or without reduced glutathione: A randomized trial in patients operated on for endometrial cancer. Tumori 78: 374-376
94. Heusinkveld RS et al. (1978) Control of radiation-induced diarrhea with cholestyramine. Int J Radiat Oncol Biol Phys 4: 687-690
95. Baughan CA et al. (1993) A randomized trial to assess the efficacy of 5-aminosalicylic acid for the prevention of radiation enteritis. Clin Oncol (R Coll Radiol) 5: 19-24
96. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231: 232-235
97. Kochhar R et al. (1991) Radiation-induced proctosigmoiditis. Prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate. Dig Dis Sci 36: 103-107
98. Goldstein F et al. (1976) Treatment of chronic radiation enteritis and colitis with salicylazosulfapyridine and systemic corticosteroids. A pilot study. Am J Gastroenterol 65: 201-208
99. Kennedy M et al. (2001) Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C. Am J Gastroenterol 96: 1080-1084
100. Ben-Josef E et al. (2002) A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injury. Int J Radiat Oncol Biol Phys 53: 1160-1164
101. Montana GS et al. (1992) Topical application of WR-2721 to prevent radiation-induced proctosigmoiditis. A phase I/II trial. Cancer 69: 2826-2830
102. Yoshimura K et al. (2000) Radiation enteritis: A rare complication of the transverse colon in uterine cancer. Intern Med 39: 1060-1063